Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The hypertension trials

P S Sever1, J A Mackay

  • 1Department of Clinical Pharmacology and Therapeutics, Imperial College of Science, Technology and Medicine, St Mary's Hospital, London, UK.

Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|September 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tissue Doppler echocardiography predicts long-term cardiovascular mortality: the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) legacy 20-year follow-up study.

Open heart·2025
Same author

Advanced drug delivery 2020 - Parts 1,2 and 3.

Advanced drug delivery reviews·2020
Same author

A collimating device for cobalt 60 teletherapy units.

The Journal of the Faculty of Radiologists. Faculty of Radiologists (Great Britain)·2014
Same author

A quantitative recipe for engineering protein polymer nanoparticles.

Polymer chemistry·2014
Same author

ASCORE: an up-to-date cardiovascular risk score for hypertensive patients reflecting contemporary clinical practice developed using the (ASCOT-BPLA) trial data.

Journal of human hypertension·2013
Same author

Kinetic quantification of protein polymer nanoparticles using non-invasive imaging.

Integrative biology : quantitative biosciences from nano to macro·2012
Same journal

Effect of melatonin, captopril, spironolactone and simvastatin on blood pressure and left ventricular remodelling in spontaneously hypertensive rats.

Journal of hypertension. Supplement : official journal of the International Society of Hypertension·2009
Same journal

Hypertension and kidney alterations in rat offspring from low protein pregnancies.

Journal of hypertension. Supplement : official journal of the International Society of Hypertension·2009
Same journal

Comparison of the effects of indapamide and captopril on the development of spontaneous hypertension.

Journal of hypertension. Supplement : official journal of the International Society of Hypertension·2009
Same journal

The protective effect of irbesartan in rats fed a high fat diet is associated with modification of leptin-adiponectin imbalance.

Journal of hypertension. Supplement : official journal of the International Society of Hypertension·2009
Same journal

Chronic antioxidant therapy fails to ameliorate hypertension: potential mechanisms behind.

Journal of hypertension. Supplement : official journal of the International Society of Hypertension·2009
Same journal

Endothelial dysfunction in spontaneously hypertensive rats: focus on methodological aspects.

Journal of hypertension. Supplement : official journal of the International Society of Hypertension·2009
See all related articles

Established antihypertensive treatments like diuretics and beta-blockers reduce stroke but may not fully reverse coronary heart disease. Long-term trials are now comparing newer agents, including calcium channel blockers and ACE inhibitors, against older drugs.

Area of Science:

  • Cardiology
  • Pharmacology
  • Internal Medicine

Background:

  • Antihypertensive therapy significantly reduces stroke incidence.
  • Concerns exist regarding the efficacy of established agents (diuretics, beta-blockers) in reversing coronary heart disease (CHD) in hypertensive patients.
  • The potential benefits of newer antihypertensive drug classes for CHD reversal remain under investigation.

Purpose of the Study:

  • To evaluate whether newer antihypertensive drug regimens offer advantages over established treatments for cardiovascular outcomes.
  • To address the question of whether calcium channel blocking agents and angiotensin converting enzyme inhibitors provide superior benefits compared to older drugs in managing hypertension-related cardiovascular disease.

Main Methods:

  • Conducting long-term morbidity and mortality trials.

Related Experiment Videos

  • Comparing treatment regimens based on newer agents (calcium channel blockers, angiotensin converting enzyme inhibitors) with established agents (diuretics, beta-blockers).

    • Main Results:

    • Previous studies confirm antihypertensive therapy's benefit in reducing stroke incidence.
    • Evidence regarding the effectiveness of established agents in reversing coronary heart disease is limited.
    • Ongoing trials are designed to provide data on the comparative efficacy of newer versus older antihypertensive drugs.

    Conclusions:

    • While established antihypertensive drugs effectively reduce stroke, their role in reversing coronary heart disease requires further clarification.
    • Long-term trials investigating calcium channel blockers and angiotensin converting enzyme inhibitors are crucial for determining optimal antihypertensive strategies.
    • The comparative advantages of newer antihypertensive agents over diuretics and beta-blockers in managing cardiovascular risk are under active investigation.